REMS – Page 4 – Policy & Medicine

FDA REMS to Promote Closer Ties to Healthcare Professionals

FDA REMS: Blue Print for Prescriber Continuing Education Program for Extended Release-Long Acting Opioids

Physician Payment Sunshine: French Parliament Takes Up Industry Physician Payment Transparency

FDA Opioid REMS: White House Proposes Mandated Certified CME

Risk Evaluation and Mitigation Strategies (REMS) Summary

FDA Opioid REMS: ACPE Outlines Pharmacists Role in Education

FDA Opioid REMS Advisory Panel Focus on CME for Improving Practice

FDA Pain REMS Advisory Committee to Include Presentations on Continuing Education in the Health Professions as a Tool for Implementation